{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:10:20Z","timestamp":1760267420748},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijcard.2016.06.123","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T02:01:58Z","timestamp":1466733718000},"page":"383-384","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Bipolar disorder, ischemic stroke, mitral valve vegetation and recurrent venous thrombosis due to antiphospholipid syndrome despite rivaroxaban"],"prefix":"10.1016","volume":"221","author":[{"given":"Jennifer","family":"Rokos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Heger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"St\u00f6llberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Finsterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnther","family":"Laufer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.06.123_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2016.06.123_bb0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.53.1.126","article-title":"Baseline NIH stroke scale score strongly predicts outcome after stroke: a report of the Trial of Org 10,172 in Acute Stroke Treatment (TOAST)","volume":"53","author":"Adams","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ijcard.2016.06.123_bb0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2014.01.006","article-title":"Diagnosis and classification of the antiphospholipid syndrome","volume":"48\u201349","author":"G\u00f3mez-Puerta","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ijcard.2016.06.123_bb0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0891988712436691","article-title":"A patient with bipolar disorder and antiphospholipid syndrome","volume":"25","author":"Avari","year":"2012","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2016.06.123_bb0025","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0049-3848(15)50445-3","article-title":"Neuropsychiatric presentations of antiphospholipid antibodies","volume":"135","author":"Gris","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2016.06.123_bb0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.autrev.2014.11.003","article-title":"Antiphospholipid syndrome and the heart: a case series and literature review","volume":"14","author":"Denas","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ijcard.2016.06.123_bb0035","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.STR.0000154858.27353.df","article-title":"Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study","volume":"36","author":"Erdogan","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2016.06.123_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11926-011-0223-5","article-title":"The management of stroke in antiphospholipid syndrome","volume":"14","author":"Panichpisal","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ijcard.2016.06.123_bb0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11926-014-0478-8","article-title":"Pulmonary hypertension in antiphospholipid syndrome","volume":"17","author":"Zuily","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ijcard.2016.06.123_bb0050","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2362.2010.02263.x","article-title":"Neurological manifestations of antiphospholipid syndrome","volume":"40","author":"Rodrigues","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ijcard.2016.06.123_bb0055","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.thromres.2012.01.011","article-title":"Antiphospholipid syndrome patients: the performance of Coaguchek XS in the monitoring of vitamin K-antagonists","volume":"129","author":"Barcellona","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2016.06.123_bb0060","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00277-015-2374-3","article-title":"Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome","volume":"94","author":"Isert","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ijcard.2016.06.123_bb0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10067-015-3030-y","article-title":"Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases","volume":"35","author":"Signorelli","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.ijcard.2016.06.123_bb0070","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1160\/TH14-03-0272","article-title":"Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients","volume":"112","author":"Schaefer","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2016.06.123_bb0075","doi-asserted-by":"crossref","DOI":"10.1097\/MBC.0000000000000541","article-title":"Bilateral adrenal gland hemorrhage in a patient treated with rivaroxaban","author":"Comuth","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.ijcard.2016.06.123_bb0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0961203315611495","article-title":"Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial","volume":"25","author":"Pengo","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.ijcard.2016.06.123_bb0085","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0961203315581207","article-title":"Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II\/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE","volume":"24","author":"Cohen","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.ijcard.2016.06.123_bb0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1076029615615960","article-title":"Apixaban for the secondary prevention of thrombosis among patients with antiphospholipid syndrome: study rationale and design (ASTRO-APS)","volume":"22","author":"Woller","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316311317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316311317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T21:53:05Z","timestamp":1536616385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316311317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":18,"alternative-id":["S0167527316311317"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.123","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bipolar disorder, ischemic stroke, mitral valve vegetation and recurrent venous thrombosis due to antiphospholipid syndrome despite rivaroxaban","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}